I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Dual MEK/AKT inhibition with trametinib and GSK2141795 does..:
Algazi, Alain P
;
Esteve-Puig, Rosaura
;
Nosrati, Adi
...
qt1sv2771g. , 2018
Link:
https://escholarship.org/uc/item/1sv2771g
RT Journal T1
Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt1sv2771g&Exemplar=1&LAN=DE A1 Algazi, Alain P A1 Esteve-Puig, Rosaura A1 Nosrati, Adi A1 Hinds, Brian A1 Hobbs-Muthukumar, Adele A1 Nandoskar, Prachi A1 Ortiz-Urda, Susana A1 Chapman, Paul B A1 Daud, Adil PB eScholarship, University of California YR 2018 K1 Humans K1 Melanoma K1 Skin Neoplasms K1 Diamines K1 Pyrazoles K1 Pyridones K1 Pyrimidinones K1 GTP Phosphohydrolases K1 MAP Kinase Kinase 1 K1 Membrane Proteins K1 Protein Kinase Inhibitors K1 Treatment Outcome K1 Survival Rate K1 Cohort Studies K1 Mutation K1 Adult K1 Aged K1 80 and over K1 Middle Aged K1 Female K1 Male K1 Proto-Oncogene Proteins c-akt K1 Young Adult K1 AKT K1 NRAS K1 GSK2141795 K1 MEK K1 trametinib K1 wild type K1 Cancer K1 Clinical Research K1 Biological Sciences K1 Medical and Health Sciences K1 Dermatology & Venereal Diseases JF qt1sv2771g LK http://dx.doi.org/https://escholarship.org/uc/item/1sv2771g DO https://escholarship.org/uc/item/1sv2771g SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)